August 3, 2006; doi:10.1152/ajpregu.00168.2006.-Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that predominantly affects women during their reproductive years. Although women with SLE have hypertension, the underlying mechanisms for this have not been examined. Despite the fact that inflammation is associated with altered endothelial and vascular function, the role of altered vascular function in the development of hypertension during SLE is unclear. In the present study, we tested whether a mouse model of SLE (NZBWF1) develops hypertension and examined whether increased blood pressure was associated with impaired endothelial-dependent relaxation. Female NZBWF1 mice were studied at 8, 20, and 36 wk of age. By 36 wk, urinary albumin and antinuclear antibodies were increased in SLE compared with control mice. Mean arterial pressure, measured by radiotelemetry, was significantly increased in SLE mice (124 Ϯ 4 mmHg, n ϭ 10) compared with control NZW/LacJ mice (111 Ϯ 3 mmHg, n ϭ 7) at 36 wk. Isolated carotid arteries from NZBWF1 mice, precontracted with U-46619 for assessment of endothelialdependent relaxation, demonstrated a progressively impaired relaxation to ACh with age, although endothelial nitric oxide synthase mRNA expression was not different. Maximal tension generated by 5-hydroxytryptamine was increased in carotid arteries from NZBWF1 mice compared with controls at 8, 20, and 36 wk of age, suggesting a role for altered vascular function early on in the progression of SLE. Taken together, our data support a role for altered endothelial function as a contributing factor to the development of hypertension during SLE. systemic lupus erythematosus; autoimmune; hypertension; endothelial; pressure; auto-antibody SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) is a complex genetic autoimmune disorder that leads to the production of antibodies against an individual's own healthy tissues. Any organ system can be affected during SLE, although individuals often present with skin rashes, joint pain, and renal problems. While no known cure for SLE exists, current immunosuppressive therapies have markedly reduced shortterm mortality rates. Long-term mortality rates, on the other hand, are increasingly influenced by cardiovascular complications. Indeed, individuals with SLE are at an alarmingly high risk for stroke, myocardial infarction, atherosclerosis, renal disease, and hypertension.Interestingly, SLE predominantly affects women (at a ratio of 9:1 women-men) during reproductive years, a period when they are typically thought to be "protected" against the development of cardiovascular disease. During this time, women with SLE are Ͼ50 times more likely to develop cardiovascular disease independent of traditional Framingham risk factors (23), with a high prevalence of hypertension, atherosclerosis, and glomerulosclerosis (1,34,38). Despite the high incidence of hypertension and peripheral vascular disease, there have been few studies directed at understanding the mechanisms of hypertension during SL...